Paton Chris, Kobayashi Shinji
University of Oxford, UK.
IMIA Open Source Working Group.
Yearb Med Inform. 2019 Aug;28(1):47-51. doi: 10.1055/s-0039-1677898. Epub 2019 Apr 25.
Artificial Intelligence (AI) offers significant potential for improving healthcare. This paper discusses how an "open science" approach to AI tool development, data sharing, education, and research can support the clinical adoption of AI systems.
In response to the call for participation for the 2019 International Medical Informatics Association (IMIA) Yearbook theme issue on AI in healthcare, the IMIA Open Source Working Group conducted a rapid review of recent literature relating to open science and AI in healthcare and discussed how an open science approach could help overcome concerns about the adoption of new AI technology in healthcare settings.
The recent literature reveals that open science approaches to AI system development are well established. The ecosystem of software development, data sharing, education, and research in the AI community has, in general, adopted an open science ethos that has driven much of the recent innovation and adoption of new AI techniques. However, within the healthcare domain, adoption may be inhibited by the use of "black-box" AI systems, where only the inputs and outputs of those systems are understood, and clinical effectiveness and implementation studies are missing.
As AI-based data analysis and clinical decision support systems begin to be implemented in healthcare systems around the world, further openness of clinical effectiveness and mechanisms of action may be required by safety-conscious healthcare policy-makers to ensure they are clinically effective in real world use.
人工智能(AI)在改善医疗保健方面具有巨大潜力。本文探讨了一种针对人工智能工具开发、数据共享、教育和研究的“开放科学”方法如何支持人工智能系统在临床中的应用。
为响应2019年国际医学信息学协会(IMIA)年鉴主题问题关于医疗保健领域人工智能的参与呼吁,IMIA开源工作组对近期与医疗保健领域开放科学和人工智能相关的文献进行了快速回顾,并讨论了开放科学方法如何有助于克服在医疗保健环境中采用新人工智能技术的担忧。
近期文献表明,人工智能系统开发的开放科学方法已得到充分确立。人工智能社区的软件开发、数据共享、教育和研究生态系统总体上采用了开放科学的理念,这推动了近期许多新人工智能技术的创新和应用。然而,在医疗保健领域,由于使用“黑箱”人工智能系统(仅了解这些系统的输入和输出,缺乏临床有效性和实施研究),其应用可能会受到阻碍。
随着基于人工智能的数据分析和临床决策支持系统开始在世界各地的医疗保健系统中实施,注重安全的医疗保健政策制定者可能需要进一步开放临床有效性和作用机制,以确保这些系统在实际应用中具有临床有效性。